Changmao Biochemical Engineering Company Limited (HKG:0954)
Hong Kong · Delayed Price · Currency is HKD 0.2190
+0.0010 (0.46%)
Sep 11, 2026, 3:58 PM HKT
HKG:0954 Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 116 | 151 | 212 | 313 | 371 | 360 | |
Market Cap Growth | -33.64% | -28.75% | -32.20% | -15.71% | 2.94% | 15.25% |
Enterprise Value | 634 | 665 | 709 | 639 | 513 | 375 |
Last Close Price | 0.22 | 0.28 | 0.40 | 0.59 | 0.64 | 0.63 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | 4.03 | 5.03 |
PS Ratio | 0.18 | 0.24 | 0.34 | 0.45 | 0.45 | 0.54 |
PB Ratio | 0.20 | 0.26 | 0.34 | 0.44 | 0.42 | 0.42 |
P/TBV Ratio | 0.20 | 0.26 | 0.34 | 0.44 | 0.42 | 0.42 |
P/FCF Ratio | 9.98 | 12.70 | - | - | - | - |
P/OCF Ratio | 2.13 | 6.95 | - | - | 16.71 | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.96 | 1.07 | 1.14 | 0.91 | 0.62 | 0.56 |
EV/EBITDA Ratio | 11.30 | 43.43 | - | 9.47 | 3.61 | 50.23 |
EV/EBIT Ratio | - | - | - | 26.85 | 4.71 | - |
EV/FCF Ratio | 54.53 | 55.91 | - | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.96 | 1.04 | 0.92 | 0.76 | 0.37 | 0.13 |
Debt / EBITDA Ratio | 10.06 | 32.16 | - | 7.69 | 2.27 | 10.61 |
Debt / FCF Ratio | 48.55 | 50.45 | - | - | - | - |
Net Debt / Equity Ratio | 0.88 | 0.91 | 0.79 | 0.61 | 0.29 | 0.04 |
Net Debt / EBITDA Ratio | 9.85 | 33.97 | -32.70 | 6.50 | 1.81 | 5.03 |
Net Debt / FCF Ratio | 44.62 | 43.73 | -4.79 | -2.81 | -1.12 | -0.17 |
Asset Turnover | 0.49 | 0.46 | 0.47 | 0.52 | 0.68 | 0.61 |
Inventory Turnover | 4.08 | 4.17 | 4.12 | 3.91 | 3.87 | 3.96 |
Quick Ratio | 0.22 | 0.28 | 0.25 | 0.61 | 0.66 | 0.68 |
Current Ratio | 0.44 | 0.50 | 0.49 | 1.04 | 1.32 | 1.24 |
Return on Equity (ROE) | -8.66% | -12.22% | -11.05% | -12.10% | 11.02% | 8.64% |
Return on Assets (ROA) | -0.48% | -1.93% | -2.84% | 1.10% | 5.57% | -1.44% |
Return on Invested Capital (ROIC) | -0.95% | -3.69% | -5.41% | 2.10% | 10.31% | -2.31% |
Return on Capital Employed (ROCE) | -1.50% | -5.90% | -8.80% | 2.40% | 10.30% | -3.00% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -45.68% | -49.21% | -34.27% | -30.34% | 24.82% | 19.87% |
FCF Yield | 10.02% | 7.88% | -48.36% | -49.89% | -62.16% | -62.54% |
Dividend Yield | - | - | - | - | 13.51% | - |
Payout Ratio | - | - | - | - | - | 18.17% |
Total Shareholder Return | - | - | - | - | 13.51% | - |